EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF RGD-mda-7, A HIS-TAGGED mda-7/IL-24 MUTANT PROTEIN
- 3 February 2012
- journal article
- research article
- Published by Taylor & Francis in Journal of Immunoassay and Immunochemistry
- Vol. 33 (4) , 352-368
Abstract
RGD peptide (Arg-Gly-Asp tripeptide) binds to integrin αVβ3 and αVβ5, which is selectively expressed in tumor neovasculature and on the surface of some tumor cells. Some studies showed that coupling the RGD peptides to anticancer drugs yielded compounds with increased efficiency against tumors and lowered toxicity to normal tissues. The melanoma differentiation-associated gene-7/interleukin-24 gene (mda-7/IL-24) is a novel tumor-suppressor/cytokine gene that exhibits potent tumor-suppressive activity without damaging normal cells. To enhance the antitumor effect, we inserted a glycine residue into the wild type (mda-7/IL-24) between 164Arg and 165Asp to form a RGD peptide, named RGD-mda-7, then expressed RGD-mda-7 in Escherichia coli. Herein, we describe the expression and purification of RGD-mda-7. We detected the characterizations of immunostimulatory activity, tumor targeting, potent cytopathic effect, and apoptosis inducing exploited by RGD-mda-7 in tumor cells, and also compared these characterizations with wtmda-7/IL-24. The data showed that RGD-mda-7 had more potent tumor targeting and apoptosis-inducing effects than wtmda-7/IL-24.Keywords
This publication has 20 references indexed in Scilit:
- Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3Targeted Radiotracers for Tumor ImagingMolecular Pharmaceutics, 2006
- Is mda-7/IL-24 a “Magic Bullet” for Cancer?Cancer Research, 2005
- Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cellsOncogene, 2005
- Intratumoral Injection of INGN 241, a Nonreplicating Adenovector Expressing the Melanoma-Differentiation Associated Gene-7 (mda-7/IL24): Biologic Outcome in Advanced Cancer PatientsMolecular Therapy, 2005
- mda-7/IL-24: Exploiting Cancer's Achilles' HeelMolecular Therapy, 2005
- MDA-7/IL-24 is a unique cytokine–tumor suppressor in the IL-10 FamilyInternational Immunopharmacology, 2004
- Integrins: roles in cancer development and as treatment targetsBritish Journal of Cancer, 2004
- Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent mannerOncogene, 2003
- Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced AngiogenesisCurrent Drug Targets, 2003
- The melanoma differentiation associated gene mda-7 suppresses cancer cell growth.Proceedings of the National Academy of Sciences, 1996